[go: up one dir, main page]

AU2001230490A1 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
AU2001230490A1
AU2001230490A1 AU2001230490A AU3049001A AU2001230490A1 AU 2001230490 A1 AU2001230490 A1 AU 2001230490A1 AU 2001230490 A AU2001230490 A AU 2001230490A AU 3049001 A AU3049001 A AU 3049001A AU 2001230490 A1 AU2001230490 A1 AU 2001230490A1
Authority
AU
Australia
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001230490A
Inventor
Arun Shriniwas Gosavi
Abdul Rehman Khan
Kishan Vishwanth Kondawar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001230490A1 publication Critical patent/AU2001230490A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
AU2001230490A 2000-12-01 2000-12-01 Pharmaceutical formulation Abandoned AU2001230490A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2000/000115 WO2002043707A1 (en) 2000-12-01 2000-12-01 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
AU2001230490A1 true AU2001230490A1 (en) 2002-06-11

Family

ID=11076282

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001230490A Abandoned AU2001230490A1 (en) 2000-12-01 2000-12-01 Pharmaceutical formulation

Country Status (3)

Country Link
EP (1) EP1414417A1 (en)
AU (1) AU2001230490A1 (en)
WO (1) WO2002043707A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017221268A1 (en) * 2016-06-21 2017-12-28 Laila Nutraceuticals Taste masking formulation for bitter natural compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
NL193682C (en) * 1987-05-14 2000-07-04 Glaxo Group Ltd Coated Cefuroxime Maxetil Composition.
AT413647B (en) * 1998-11-26 2006-04-15 Sandoz Ag USE OF A COPOLYMERISATE OF 1-VINYL-2-PYRROLIDONE AND VINYL ACETATE FOR THE PREPARATION OF CEFUROXIMAXETIL-SUBJECTED TABLETS
US6210716B1 (en) * 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
KR100342943B1 (en) * 1999-08-04 2002-07-02 민경윤 Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration comprising same

Also Published As

Publication number Publication date
WO2002043707A1 (en) 2002-06-06
EP1414417A4 (en) 2004-05-06
EP1414417A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2002257582A1 (en) Pharmaceutical formulation
AU2001295657A1 (en) Formulation containing wax-esters
AU4328800A (en) Pharmaceutical formulation
AU3556400A (en) Pharmaceutical compositions
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2001283344A1 (en) Dermatological formulation
AU6715600A (en) Pharmaceutical formulations
AU2001273919A1 (en) Pharmaceutical compositions
AU4977300A (en) Pharmaceutical formulations
AU2001232244A1 (en) Drug comprising combination
AU1385801A (en) Pharmaceutical formulations
AU4085201A (en) Pharmaceutical composition
AU3839900A (en) Pharmaceutical formulation
AUPR099200A0 (en) New formulation
AU3586401A (en) Pharmaceutical composition
AU2001292578A1 (en) Pharmaceutical compounds
AU5182099A (en) Pharmaceutical formulation
AU1388501A (en) Pharmaceutical formulation
AU2001278705A1 (en) Pharmaceutical composition
GB0014851D0 (en) Novel pharmaceutical formulation
AU2001282541A1 (en) Medicinal compositions